Pri-med Podcasts

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 128:00:47
  • More information

Informações:

Synopsis

A primary care podcast featuring expert faculty answering frequently asked questions on a given therapeutic area. These podcasts are captured directly after Pri-Meds live conference sessions.

Episodes

  • Reducing the Risk of Alcohol-Associated Liver Disease - Frankly Speaking EP 292

    05/09/2022 Duration: 12min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-292   Overview: Alcohol use disorder is common, but effective medications to treat this disorder are not widely prescribed in the outpatient primary care setting, despite being available and having relatively good formulary coverage. Join us to hear how the use of medical treatment can decrease the incidence and progression of alcohol-associated liver disease.   Episode resource links: Augustin G. L. Vannier et al, Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder, JAMA Network Open (2022).  DOI: 10.1001/jamanetworkopen.2022.13014     Tetreault JM, O'Connor PG. Risky drinking and alcohol use disorder: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis. UpToDate. Published April 28, 2022. Accessed June 11, 2022.    Holt SR, Tetrault, JM. Ambulatory Management of al

  • Is Less More When Treating BP in Older Adults? - Frankly Speaking EP 291

    29/08/2022 Duration: 10min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-291   Overview: Concerns have been raised over guideline recommendations for lowering systolic blood pressure (BP) to 60 years. To achieve such targets often requires intensive BP treatments, which can result in harms from syncope or falls. Join us to review the results of a recently published meta-analysis done to estimate the time needed to potentially derive clinical benefit from such BP treatments in patients 60 years and older.    Episode resource links: JAMA Intern Med. 2022;182(6):660-667. doi:10.1001/jamainternmed.2022.1657   Guest: Robert A. Baldor, MD   Music Credit: Richard Onorato

  • When Do Food Allergies Resolve? - Frankly Speaking EP 290

    22/08/2022 Duration: 10min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-290   Overview: This brief podcast discusses the prevalence of egg and nut allergies in children, how to lower the risk of developing these allergies, and which patients are at greatest risk. Hear how to best counsel parents about their child’s allergies and help them anticipate their child’s future health.   Episode resource links: The natural history of peanut and egg allergy in children up to age 6 years in the HealthNuts population-based longitudinal study; Am Aca Allergy, Asthma & Immunol 2022; https://doi.org/10.1016/j.jaci.2022.04.008 Dietary Interventions to pRevent Atopic Disease in Children, AAP 3/19: https://publications.aap.org/aapnews/news/8699   Guest: Jill M. Terrien PhD, ANP-BC   Music Credit: Richard Onorato

  • Limit Screen Time to Increase Physical Activity - Frankly Speaking Ep 289

    15/08/2022 Duration: 08min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-289 Overview: Excessive screen time has been associated with numerous adverse health outcomes. Join us for a look at a fascinating new study that explores how limiting screen time can increase physical activity in children. Listen to this brief podcast before you counsel your next patient on how screen time can affect their children’s (and their) health. Episode resource links: Pedersen J,et al. Effects of Limiting Recreational Screen Media Use on Physical Activity and Sleep in Families With Children: A Cluster Randomized Clinical Trial. JAMA Pediatr. 2022 May 23:e221519   Screen Time and Children. American Academy of Child and Adolescent Psychiatry: https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/Children-And-Watching-TV-054.aspx Guest: Alan Ehrlich MD, FAAFP   Music Credit: Richard Onorato

  • A Spoonful of Sugar in Your Cup of Joe—Does It Affect Your Health? - Frankly Speaking Ep 288

    08/08/2022 Duration: 09min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-288 Overview: Coffee is one of the most consumed beverages worldwide. An estimated 500 million cups are consumed per day in the United States. As testimony to this, count the number of coffee shops available—most with drive-through access—the next time you are out for a drive. A growing body of evidence indicates that moderate coffee consumption (2-3 cups per day) is associated with reduction in all-cause mortality. What hasn’t been looked at closely is the effect of coffee with sugar and artificial sweeteners on these measures. Join us while we discuss recent evidence regarding consumption of coffee—with or without sweeteners—and its association with all-cause mortality. Episode resource links: Liu D, Li ZH, Shen D, Zhang PD, Song WQ, Zhang WT, Huang QM, Chen PL, Zhang XR, Mao C. Association of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Coffee Con

  • Biennial Screening Could Decrease False Positives in Screening Mammography - Frankly Speaking Ep 287

    01/08/2022 Duration: 10min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-287 Overview: Join us to discuss the rates of false positives in mammography and how to decrease them. Specifically, this session reviews data from an observational comparative effectiveness study suggesting that the type of mammography, interval, and other factors can affect the probability of false positive results.  Episode resource links: Ho TH, Bissell MCS, Kerlikowske K, et al. Cumulative Probability of False-Positive Results After 10 Years of Screening With Digital Breast Tomosynthesis vs Digital Mammography. JAMA Netw Open. 2022;5(3):e222440. doi:10.1001/jamanetworkopen.2022.2440 Breast Cancer Screening Guidelines for Women (CDC Chart)—Last reviewed 9-2020 chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.cdc.gov/cancer/breast/pdf/breast-cancer-screening-guidelines-508.pdf Canelo-Aybar, C., Posso, M., Montero, N. et al. Benefits and harms o

  • Struggling with Weight Loss: Case Conversations in Type 2 Diabetes

    27/07/2022 Duration: 21min

    Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/struggling-with-weight-loss In the context of a clinical case, faculty will explain how to use patient-centered communication to present pharmacotherapeutic options for weight loss and blood glucose management that follow evidence-based guidelines.

  • USPSTF: Aspirin No Longer Recommended for Primary Prevention - Frankly Speaking Ep 286

    25/07/2022 Duration: 10min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-286 Overview: The controversy surrounding whether to prescribe aspirin for primary prevention of cardiovascular disease in adult patients has left many clinicians unsure of the right approach. In this podcast, we’ll review the latest USPSTF recommendation on this topic and dig into the evidence behind the recommendation. Episode resource links: JAMA. 2022;327(16):1577-1584. doi:10.1001/jama.2022.4983 Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato

  • Tirzepatide: A New Treatment for Diabetes - Frankly Speaking Ep 285

    18/07/2022 Duration: 11min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-285 Overview: Join us for a closer look at tirzepatide, a first-in-class glucose-dependent insulinotropic peptide (GIP) and a glucagon-like peptide-1 receptor agonist (GLP-1 RA). See how this novel glucose-lowering agent can help raise the bar in both HbA1c lowering and weight loss in patients with type 2 diabetes mellitus. Episode resource links: Karagiannis T, Avgerinos I, Liakos A, Del Prato S, Matthews DR, Tsapas A, Bekiari E. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022 May 17:1–11. Guest: Alan Ehrlich MD, FAAFP   Music Credit: Richard Onorato

  • What Are the Best Agents to Treat Male Baldness? - Frankly Speaking Ep 284

    11/07/2022 Duration: 09min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-284 Overview: Most primary care clinicians treating patients with male androgenetic alopecia are unfamiliar with studies looking at off-label use of medications for this condition. In this episode, you will hear a review of an important recent meta-analysis published in JAMA Dermatology that highlights the efficacy of commonly used agents to treat this condition. Episode resource links: JAMA Dermatol. doi:10.1001/jamadermatol.2021.5743 Guest: Robert A. Baldor MD, FAAFP   Music Credit: Richard Onorato

  • Clearing the Air in COPD - Frankly Speaking Ep 283

    04/07/2022 Duration: 10min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-283 Overview: Listen to this podcast to hear a simple method to help those with COPD improve their symptom control and lower exacerbation rates.  Episode resource links: Am J Respir Crit Care Med Vol 205, Iss 4, pp 421–430, Feb 15, 2022 Guest: Jillian Joseph, MSPAS, PA-C  Music Credit: Richard Onorato

  • The Case of a Patient with Migraine and Cardiovascular Disease

    01/07/2022 Duration: 15min

    Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/migraine-and-cardiovascular-disease-case Overview: This podcast will focus on the case of a patient with a long history of periodic migraine attacks whose previously preferred acute medication is now contraindicated because of a recently acquired comorbid condition. Faculty will consider newer medication options for this patient that will take into account his employment requirements and individual preferences, as well as his medical history.

  • Your Questions About Migraine Answered

    01/07/2022 Duration: 17min

    Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/your-questions-about-migraine Overview: In this podcast, Dr. Dawn Buse will address questions about migraine diagnosis and treatment posed by Pri-Med learners during recent programs. Topics will include deciding when imaging is appropriate in the evaluation of headache, distinguishing between migraine and cluster headache, determining which patients would benefit from preventive migraine therapy, considering how long to use a preventive therapy before determining it to be ineffective, managing menstrual migraines, and treating migraine in children and adolescents.

  • A Primer on Monkeypox - Frankly Speaking Ep 282

    27/06/2022 Duration: 14min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-282 Overview: Monkeypox is endemic in certain parts of Africa, but outbreaks in Europe and North America have recently occurred. While still uncommon, clinicians need to be alert to the possibility of this diagnosis. This podcast gives you the tools you need to identify risk factors and distinguish the disease from other infections. Episode resource links: World Health Organization Health Topics/Monkeypox https://www.who.int/health-topics/monkeypox#tab=tab_1   Disease outbreak New/Item/Multi-country monkeypox outbreak: situation update 6-10-2022 https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON392 Guest: Alan Ehrlich MD, FAAFP   Music Credit: Richard Onorato

  • Access to Care: Safety of Medication Abortion - Frankly Speaking Ep 281

    20/06/2022 Duration: 12min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-281 Overview: Clinicians may hesitate to provide medication abortion without first performing a pelvic ultrasound or pelvic examination, but recent data may give clinicians more confidence in their decision to do so. This episode explores the evidence for the safety of telehealth-based, or no-test screening, approaches to providing medication abortion for pregnant women at less than 10 weeks’ gestation.  Episode resource links: Upadhyay UD, Raymond EG, Koenig LR, et al. Outcomes and Safety of History-Based Screening for Medication Abortion: A Retrospective Multicenter Cohort Study. JAMA Intern Med. Published online March 21, 2022. doi:10.1001/jamainternmed.2022.0217 Upadhyay UD, Koenig LR, Meckstroth KR. Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic. JAMA Network Open. 2021;4(8):e2122320. doi:10.1001/jamanetworkope

  • Emerging Solutions for Cancer Screening Challenges: Multi-Cancer Early Detection

    17/06/2022 Duration: 18min

    Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/multi-cancer-early-detection Overview: Carve out 15 minutes in your day to listen to an expert-led podcast on the current landscape of cancer screening and how emerging technology in multi-cancer early detection (MCED) screening tests will likely improve this landscape. Listen while experts define this new technology, explain how it works, and discuss its benefits and limitations. Find out how available and emerging MCED tests can augment your current screening strategies and optimize cancer detection, potentially catching a greater number of early-stage cancers and saving lives.

  • Statins for Cardiovascular Disease—It’s All Relative - Frankly Speaking Ep 280

    13/06/2022 Duration: 12min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-280 Overview: Statins are widely used for lowering cholesterol in patients at risk for cardiovascular disease. While the benefit is more established with secondary prevention compared with primary prevention, most of the benefits are reported in relative risk reduction, which can exaggerate the benefit to an individual person. In this podcast, you’ll hear a discussion of a recent systematic review that looked at the absolute risk reduction and relative risk reduction with statins for preventing death, myocardial infarctions, and stroke. Episode resource links: Byrne, P. , Demasi, M. , Jones, M. , et al. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment. JAMA Internal Medicine Guest: Alan Ehrlich MD, FAAFP   Music Credit: Richard Onorato

  • Step It Up! But by How Much? - Frankly Speaking Ep 279

    06/06/2022 Duration: 10min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-279 Overview: Clinicians (and patients) know that walking is beneficial for overall health, but what are the specifics? How many steps per day lower health risks? What impact does walking have on mortality? What’s the best way to count steps? Join us to hear answers to these questions and more as we discuss evidence-based recommendations for steps/day. Episode resource links: Paluch, A. E., Bajpai, S., Bassett, D. R., Carnethon, M. R., Ekelund, U., Evenson, K. R., Galuska, D. A., Jefferis, B. J., Kraus, W. E., Lee, I. M., Matthews, C. E., Omura, J. D., Patel, A. V., Pieper, C. F., Rees-Punia, E., Dallmeier, D., Klenk, J., Whincup, P. H., Dooley, E. E., Pettee Gabriel, K., … Steps for Health Collaborative (2022). Daily steps and all-cause mortality: a meta-analysis of 15 international cohorts. The Lancet. Public health, 7(3), e219–e228. https://doi.org/10.1016/S

  • Forget About Weed - Frankly Speaking Ep 278

    30/05/2022 Duration: 09min

    Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-278 Overview: Misconceptions abound on the long-term effects of chronic use of marijuana. This episode tackles these misconceptions head-on, highlighting new data on marijuana’s adverse effects on central nervous system function, including loss of memory, IQ points, and executive functioning. It’s a must-listen for clinicians caring for patients engaging in regular marijuana use. Episode resource links: Am J Psych 8 Mar 2022 https://doi.org/10.1176/appi.ajp.2021.21060664 Guest: Jillian Joseph, MSPAS, PA-C   Music Credit: Richard Onorato

  • New and Emerging Therapies for Alzheimer Disease: Anti-Amyloid Therapies

    26/05/2022 Duration: 12min

    Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/Podcast/alzheimer-disease-detection-pt2 Overview: This short podcast will focus on new and emerging monoclonal antibody therapies targeting β-amyloid, with a focus on the importance of early recognition and diagnosis of Alzheimer disease to allow prompt treatment for patients in the early stages of the disease who may derive the most benefit from these agents.

page 11 from 28